AVITA Medical, Inc. (RCEL) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -10.07M | -5.44M | -5.22M | -10.23M | -10.31M | -8.08M | -7.21M | -12.78M | -20.86M | -10.86M | -8.97M | -9.1M |
| Operating CF Margin % | -52.32% | -30.87% | -30.59% | -55.54% | -55.68% | -43.9% | -36.91% | -84.11% | -187.9% | -76.53% | -65.77% | -77.44% |
| Operating CF Growth % | 2.3% | 32.71% | 27.65% | 19.96% | 50.59% | 25.61% | 19.61% | -40.42% | -129.96% | -216.15% | -223.15% | -159.51% |
| Net Income | -10.61M | -11.62M | -13.19M | -9.92M | -13.86M | -11.59M | -16.2M | -15.39M | -18.66M | -7.07M | -8.71M | -10.38M |
| Depreciation & Amortization | 627K | 392K | 574K | 552K | 521K | 409K | 310K | 204K | 203K | 187K | 164K | 146K |
| Stock-Based Compensation | 0 | 1.37M | 2.78M | 2.67M | 2.69M | 2.8M | 4.08M | 4.03M | 2.59M | 2.17M | 2.43M | 1.14M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.14M | 383K | 3.67M | -1.75M | 94K | 1.05M | 2.24M | -1.57M | 1.25M | -6.16M | 53K | 327K |
| Working Capital Changes | -2.23M | 4.04M | 952K | -1.79M | 241K | -746K | 2.36M | -51K | -6.25M | 3K | -2.91M | -333K |
| Change in Receivables | -799K | -81K | 2.34M | 1.63M | -253K | -1.43M | -1.53M | -1.71M | 503K | -1.53M | 208K | -1.21M |
| Change in Inventory | 752K | 198K | 144K | 629K | -1.44M | -1.12M | 306K | 312K | -1.66M | -1.29M | -1.4M | -249K |
| Change in Payables | -1.79M | 983K | 861K | -1.43M | 2.33M | 405K | 1.34M | -639K | -763K | 879K | -817K | -31K |
| Cash from Investing | 2.04M | 11K | -5.34M | 7.02M | 10.77M | 2.47M | 7.39M | 12.43M | 15.07M | -57.3M | 21.76M | 18.36M |
| Capital Expenditures | -22K | 1.68M | -934K | -524K | -221K | -1.61M | -3.76M | -2.65M | -1.15M | -296K | -502K | -299K |
| CapEx % of Revenue | 0.11% | 9.53% | 5.47% | 2.84% | 1.19% | 8.76% | 19.24% | 17.45% | 10.33% | 2.09% | 3.68% | 2.54% |
| Acquisitions | 0 | 5K | -5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -1.71M | -16K | 0 | -13K | -22K | -56K | -1K | -83K | -34K | -10K | -5K |
| Cash from Financing | 6.1M | 248K | 13.77M | 559K | 363K | 1.02M | 1.01M | 849K | 631K | 39.43M | 600K | 171K |
| Debt Issued (Net) | 6.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Equity Issued (Net) | 0 | -33.28K | 14.05M | 14.96K | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 281.28K | -285.22K | 544.04K | 363K | 1.02M | 1.01M | 849K | 631K | 39.43M | 600K | 171K |
| Net Change in Cash | -1.93M | -5.18M | 3.21M | -2.65M | 820K | -4.59M | 1.19M | 501K | -5.17M | -28.74M | 13.37M | 9.44M |
| Free Cash Flow | -10.09M | -3.73M | -6.17M | -10.75M | -10.54M | -9.71M | -11.03M | -15.43M | -22.09M | -11.19M | -9.49M | -9.4M |
| FCF Margin % | -52.42% | -21.15% | -36.19% | -58.38% | -56.95% | -52.78% | -56.43% | -101.57% | -198.97% | -78.85% | -69.52% | -80.02% |
| FCF Growth % | 4.29% | 61.66% | 44.03% | 30.32% | 52.28% | 13.2% | -16.28% | -64.09% | -135.69% | -217.44% | -226.88% | -151.4% |
| FCF per Share | -0.03 | -0.12 | -0.22 | -0.41 | -0.40 | -0.37 | -0.42 | -0.60 | -0.86 | -0.44 | -0.37 | -0.37 |
| FCF Conversion (FCF/Net Income) | 0.95x | 0.47x | 0.40x | 1.03x | 0.74x | 0.70x | 0.45x | 0.83x | 1.12x | 1.54x | 1.03x | 0.88x |
| Interest Paid | 0 | -3.74M | 1.26M | 1.25M | 1.23M | 1.3M | 1.36M | 1.35M | 1.35M | 1.12M | 10K | 7K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 20K | 2K | 2K | 17K | 0 | - | 35K |